Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation
Study Information
Alliance Study ID: NCCTG-969251
NCT Study ID (ClinicalTrials.gov): NCT00003611
Disease or Cancer Type: Melanoma & Skin Cancers
Alliance Study Chair: Mark R. Pittelkow, MD
Status: COMPLETED
Study Description
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of acitretin may be an effective way to prevent the recurrence or further development of skin cancer.
PURPOSE: Randomized clinical trial to study the effectiveness of acitretin in preventing skin cancers in patients with at least two previously treated skin cancers who have undergone organ transplantation.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information